These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 17184219)
1. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219 [TBL] [Abstract][Full Text] [Related]
2. Chemical adjuvants for plasmid DNA vaccines. Greenland JR; Letvin NL Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735 [TBL] [Abstract][Full Text] [Related]
3. DNA vaccines--challenges in delivery. Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641 [TBL] [Abstract][Full Text] [Related]
4. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species. van Drunen Littel-van den Hurk S; Babiuk SL; Babiuk LA Immunol Rev; 2004 Jun; 199():113-25. PubMed ID: 15233730 [TBL] [Abstract][Full Text] [Related]
5. Intradermal naked plasmid DNA immunization: mechanisms of action. Elnekave M; Furmanov K; Hovav AH Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310 [TBL] [Abstract][Full Text] [Related]
6. Human clinical trials of plasmid DNA vaccines. Liu MA; Ulmer JB Adv Genet; 2005; 55():25-40. PubMed ID: 16291211 [TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Anderson RJ; Schneider J Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccines: a role for liposomes. Gregoriadis G Curr Opin Mol Ther; 1999 Feb; 1(1):39-42. PubMed ID: 11249682 [TBL] [Abstract][Full Text] [Related]
10. Strategies for DNA vaccine delivery. Alpar HO; Papanicolaou I; Bramwell VW Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781 [TBL] [Abstract][Full Text] [Related]
11. DNA vaccines and their application against parasites--promise, limitations and potential solutions. Smooker PM; Rainczuk A; Kennedy N; Spithill TW Biotechnol Annu Rev; 2004; 10():189-236. PubMed ID: 15504707 [TBL] [Abstract][Full Text] [Related]
12. DNA vaccines: successes and limitations in cancer and infectious disease. Lowe DB; Shearer MH; Kennedy RC J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465 [TBL] [Abstract][Full Text] [Related]
14. Use of attenuated bacteria as delivery vectors for DNA vaccines. Daudel D; Weidinger G; Spreng S Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482 [TBL] [Abstract][Full Text] [Related]
15. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge. Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199 [TBL] [Abstract][Full Text] [Related]
16. DNA vaccines for biodefence. Garmory HS; Perkins SD; Phillpotts RJ; Titball RW Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877 [TBL] [Abstract][Full Text] [Related]
17. DNA vaccination in skin enhanced by electroporation. Broderick KE; Khan AS; Sardesai NY Methods Mol Biol; 2014; 1143():123-30. PubMed ID: 24715285 [TBL] [Abstract][Full Text] [Related]